Королева глюкозы. Пошаговый 4-недельный план формирования метаболической гибкости, снижения инсулинорезистентности, уменьшения обхвата талии — Ёнг-ву Пак

19. Bray GA. Contemporary diagnosis and management of obesity. Newtown, PA: Handbooks in Health Care, 1998.

20. McQuaid SE, et al. Downregulation of adipose tissue fatty acid trafficking in obesity: a driver for ectopic fat deposition? Diabetes. 2011; 60: 47–55.

21. DeFronzo RA. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 2009; 58: 773–795.

22. Lee SH, et al. Insulin Resistance: From Mechanisms to Therapeutic Strategies. Diabetes Metab J 2022; 46(1): 15–37.

23. Tabák AG, et al. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet. 2009; 373: 2215–2221.

24. Pearson, T, et al. The Effects of Insulin Resistance on Individual Tissues: An Application of a Mathematical Model of Metabolism in Humans. Bull Math Biol 2016; 78: 1189–1217.

25. Chen Y, Lee Y, Tsao Y, et al Association between high-fasting insulin levels and metabolic syndrome in non-diabetic middle-aged and elderly populations: a community-based study in Taiwan. BMJ Open 2018; 8:e016554. Doi: 10.1136/bmjopen-2017-016554.

26. Sung, KC.C., Seo, MH.H., Rhee, EJ.J. et al. Elevated fasting insulin predicts the future incidence of metabolic syndrome: a 5-year follow-up study. Cardiovasc Diabetol 10, 108 (2011). https://doi.org/10.1186/1475-2840-10-108

27. Jeong J, Suh YJ. Association between Serum Uric Acid and Metabolic Syndrome in Koreans. J Korean Med Sci. 2019 Dec; 34(48): e307.

28. Tanabe A, Tatsumi F, Okauchi S, et al. Optimal cut-off value of alanine aminotransferase level to precisely estimate the presence of fatty liver in patients with poorly controlled type 2 diabetes. J Diabetes Investig 2016; 7: 645–646.

29. Arner P, et al. Human white adipose tissue: A highly dynamic metabolic organ. Journal of Internal Medicine. 2022; 291(5): 611–621.

30. Spalding KL, et al. Dynamics of fat cell turnover in humans. Nature. 2008; 453: 783–787.

31. Longo M. et al. Adipose Tissue Dysfunction as Determinant of Obesity-Associated Metabolic Complications Int J Mol Sci. 2019; 20(9): 2358.

32. Lloyd LJ, et al. Childhood obesity and adult cardiovascular disease risk: a systematic review. International Journal of Obesity. 2010; 34: 18–28.

33. Wrzosek M, et al. Early Onset of Obesity and Adult Onset of Obesity as Factors Affecting Patient Characteristics Prior to Bariatric Surgery. Obes Surg. 2018; 28(12): 3902–3909.

34. Wang X, et al. Adipose Tissue Aging and Metabolic Disorder, and the Impact of Nutritional Interventions. Nutrients. 2022; 14(15): 3134.